FDA to study negative effects of Lasik eye surgery
WASHINGTON — The Food and Drug Administration says it is launching a study into problems resulting from laser eye-correcting surgery, which include blurred vision and dry eyes.
The FDA says it will work with the National Eye Institute and the Department of Defense to determine the percentage of patients who experience negative side effects following surgery.
The project includes a clinical trial tracking patients who undergo the procedure, which is expected to conclude by 2012.
"This study will enhance our understanding of the risks of Lasik and could lead to a reduction in patients who experience adverse effects," said Dr. Jeffrey Shuren, FDA's acting medical device chief.
Related News
UK's prime minister reveals he has 2 minor tears in his retina, but no surgery plannedOctober 10th, 2009 UK's Brown reveals he has 2 retina tearsLONDON — Britain's Prime Minister Gordon Brown disclosed Saturday that an eye examination showed two tears in the retina of his eye — a revelation that could embolden critics who want him to step down before a national election. Downing Street moved quickly to quash speculation over Brown's health, issuing the statement only one day after a regular examination at a London eye hospital.
Cure for glaucoma soon, says new researchOctober 6th, 2009 TORONTO - Cure for glaucoma which leads to blindness may be on its way. Canadian researchers have discovered an unidentified form of circulation in the human eye which may provide important clues to glaucoma.
Now, device that finds early signs of eye disease in preemiesSeptember 22nd, 2009 WASHINGTON - Researchers at Duke University Medical Center have developed a device that finds early signs of eye disease in premature babies. The technology uses spectral domain optical coherence tomography (SD OCT) to create a 3-D picture of the back of the eye.
Gene variant linked to glaucoma identifiedSeptember 22nd, 2009 WASHINGTON - Researchers have discovered gene variants for glaucoma. The international team, led by researchers from the University of California, San Diego School of Medicine and the National Eye Institute, claims the discovery could lead to future treatments or a cure for the disease.
Steroid injections offer 'vision restoration' hope for patients with blocked eye veinsSeptember 15th, 2009 WASHINGTON - The injections of the steroid corticosteroid triamcinolone may help restore vision in some patients with retinal vein occlusion, an important cause of vision loss that results from blockages in the blood vessels in the retina, say two research papers. Retinal vein occlusion is an important cause of vision loss worldwide, according to background information in the articles published in the September issue of Archives of Ophthalmology.
UAE charity launches eye care initiative in MoroccoSeptember 5th, 2009 ABU DHABI - The United Arab Emirates Red Crescent Authority (UAE-RCA) has launched the Emirates Anti-Glaucoma Initiative in Morocco, WAM news agency reported Saturday. The initiative plans to treat 4,000 people over next five years in five phases.
ISTA Pharma says Xibrom QD eliminated eye inflammation and eye pain after cataract surgeryAugust 26th, 2009 ISTA says daily Xibrom eye drops met goal in studyIRVINE, Calif. — ISTA Pharmaceuticals Inc.
